A drug used to treat Ebola patients has shown "promising" early results in a trial of people admitted to hospital with coronavirus, scientists have said.
Patients given remdesivir had a recovery time that was almost a third faster than those given a placebo, the first results from an international clinical trial showed.
Remdesivir, which was originally developed to treat Ebola, is one of a handful of experimental drugs undergoing clinical trials worldwide to treat coronavirus.
Asked about the drug, Sir Patrick Vallance said: "It absolutely does hit a particular part of the virus." A study in the US showed it aids recovery time by four days and trials were continuing, including one in the UK, he confirmed. "I think the answer is: this is a